Reporte de un caso: experiencias del pie diabético en el primer nivel de atención
Resumen
El pie diabético constituye una complicación microvascular asociada a neuropatía. Genera un aumento sustancial de la morbimortalidad con gran impacto a la calidad de vida del paciente, y requiere un manejo multidisciplinario para evitar complicaciones mayores. Mostramos un caso de un paciente diabético de 10 años de evolución, con controles de glucosa alterados que presenta un pie diabético secundario a quemadura y que tras varias semanas de curaciones y tratamiento antibiótico termina en injerto de piel. Conocer la evolución y manejo del pie diabético es elemental para los futuros médicos y enfermeras, quienes deben obtener habilidades necesarias para el manejo óptimo de estos pacientes.Descargas
Citas
Hu X, Xiu Z, Li G, Zhang J, Shu L, Chen Z, et al. Effectiveness of transverse tibial bone transport in treatment of diabetic foot ulcer: A systematic review and meta-analysis. Front Endocrinol. 2023; 13:1095361. doi: 10.3389/fendo.2022.1095361
Ou S, Xu C, Yang Y, Chen Y, Li W, Lu H, et al. Transverse Tibial Bone Transport Enhances Distraction Osteogenesis and Vascularization in the Treatment of Diabetic Foot. Orthop Surg. 2022; 14(9):2170-9. doi: 10.1111/os.13416
Bakker K, Apelqvist J, Lipsky B, Van Netten J, International Working Group on the Diabetic Foot. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016; 32(Suppl 1):2-6. D https://doi.org/10.1002/dmrr.2694
International Working Group on the Diabetic Foot. IWGDF Practical guidelines on the prevention and management of diabetic foot disease. [Internet]. Part of the 2019 IWGDF guidelines on the prevention and management of diabetic foot disease. 2019. Disponible en: https://iwgdfguidelines.org/wp-content/uploads/2021/03/IWGDF-2019-final.pdf
Walsh J, Hoffstad O, Sullivan M, Margolis D. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016; 33(11):1493-8. https://doi.org/10.1111/dme.13054
Kasiya M, Mang’anda G, Heyes S, Kachapila R, Kaduya L, Chilamba J, et al. The challenge of diabetic foot care: Review of the literature and experience at Queen Elizabeth Central Hospital in Blantyre, Malawi. Malawi Medical Journal. 2017; 29(2):218-223. doi: 10.4314/mmj.v29i2.26
Brocco E, Ninkovic S, Marin M, Whisstock C, Bruseghin M, Boschetti G, et al. Diabetic foot management: multidisciplinary approach for advanced lesion rescue. J Cardiovasc Surg (Torino). 2018; 59(5):670-84. doi: 10.23736/S0021-9509.18.10606-9
Armstrong D, Boulton A, Bus S. Diabetic Foot Ulcers and Their Recurrence. The New England Journal of Medicine. 2017; 376(24):2367-2375. doi: 10.1056/NEJMra1615439
Jeyaraman K, Berhane T, Hamilton M, Chandra A, Falhammar H. Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia. BMC Endocr Disord. 2019; 19:1. doi: 10.1186/s12902-018-0327-2
Wang A, Lv G, Cheng X, Ma X, Wang W, Gui J, et al. Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition). Burns Trauma. 2020; 8:tkaa017. doi: 10.1093/burnst/tkaa017
Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018; 1411(1):153-165. doi: 10.1111/nyas.13569
Diaz Rodriguez JX. Clinical and pathophysiologic aspects of diabetic foot. Medicina Interna de México. 2021; 37(4):540-550.
Bravo A, Linares J, Vera B, Salmerón L, Ros E. Inter-observer agreement of the Wagner, University of Texas and PEDIS classification systems for the diabetic foot syndrome. Foot and Ankle Surgery. 2018; 24(1):60-64. https://doi.org/10.1016/j.fas.2016.10.009
Llaguno DAP. Pie diabético. Tratamiento médico multidisciplinario y Ozonoterapia. Rev Espanola Ozonoterapia. 2018; 8(1):16.
Liu Z, Dumville J, Hinchliffe R, Cullum N, Game F, Stubbs N, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2018; 2018(10):CD010318. doi: 10.1002/14651858.CD010318.pub3
Biz C, Gastaldo S, Dalmau M, Corradin M, Volpin A, Ruggieri P. Minimally Invasive Distal Metatarsal Diaphyseal Osteotomy (DMDO) for Chronic Plantar Diabetic Foot Ulcers. Foot Ankle Int. 2018; 39(1):83-92. https://doi.org/10.1177/1071100717735
Rossaneis M, Haddad M, Mathias T, Marcon S. Differences in foot self-care and lifestyle between men and women with diabetes mellitus 1. Rev Lat Am Enfermagem. 2016; 24:e2761. doi: 10.1590/1518-8345.1203.2761
RNAO. Reducing Foot Complications for People with Diabetes. 2004. Disponible en: https://rnao.ca/bpg/guidelines/reducing-foot-complications-people-diabetes
Cruciani M, Lipsky B, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2013; (8):CD006810. doi: 10.1002/14651858.CD006810.pub3
Turner, R., Holman, R., Matthews, D., Oakes, S., Bassett, P., Stratton, I., Cull, C., Manley, S., & Frighi, V. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia. 1991; 34(12):877-890.
Hasan R, Firwana B, Elraiyah T, Domecq J, Prutsky G, Nabhan M, et al. A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome. J Vasc Surg. 2016; 63(2 Suppl):22S-28S.e1-2. doi: 10.1016/j.jvs.2015.10.005
Pereira S, Moura J, Carvalho E, Empadinhas N. Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies. Front Microbiol. 2017; 8:1791. doi: 10.3389/fmicb.2017.01791
Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes. 2018; 42 Suppl 1:S1-5. doi: 10.1016/j.jcjd.2017.10.001
Jones N, Harding K. 2015 International Working Group on the Diabetic Foot Guidance on the prevention and management of foot problems in diabetes. Int Wound J. 2015; 12(4):373-374. doi: 10.1111/iwj.12475
Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010; 2010(1):CD003556. doi: 10.1002/14651858.CD003556.pub2
Di Domenico E, De Angelis D, Cavallo L, Sivori F, Orlandi F, Fernandes Lopes Morais D’Autilio M, et al. Silver Sulfadiazine Eradicates Antibiotic-Tolerant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms in Patients with Infected Diabetic Foot Ulcers. Journal of Clinical Medicine. 2020; 9(12):3807. doi: 10.3390/jcm9123807
Wang Y, Lee H, Chen C, Kuo M, Ramachandran S, Chen R, et al. The Effects of Silver-Releasing Foam Dressings on Diabetic Foot Ulcer Healing. ournal of Clinical Medicine. 2021; 10(7):1495. doi: 10.3390/jcm10071495
Pérez A, Ruiz M, Cuesta A, Gónzalez M. Prevention, assessment, diagnosis and management of diabetic foot based on clinical practice guidelines. Medicine (Baltimore). 2019; 98(35):e16877. doi: 10.1097/MD.0000000000016877
Carro G, Carlucci E, Priore G, Gette F, Llanos M, Dicatarina Losada MV, et al. Infections in diabetic foot. Choice of empirical antibiotic regimen. Medicina (Mex). 2019; 79(3):167-173.
Wang C, Mai L, Yang C, Liu D, Sun K, Song W, et al. Reducing major lower extremity amputations after the introduction of a multidisciplinary team in patient with diabetes foot ulcer. BMC Endocr Disord. 2016; 16:38. doi: 10.1186/s12902-016-0111-0
International Working Group on the Diabetic Foot IWGDF guidelines on the prevention and management of diabetic foot disease. IWGDF Guidelines. 2019. Disponible en: https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019
Derechos de autor 2023 FACSALUD-UNEMI
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
Todos los artículos de la Revista FACSalud UNEMI son difundidos bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
Los autores mantienen los derechos de autor, y, por lo tanto, son libres de compartir, copiar, distribuir, ejecutar y comunicar públicamente la obra bajo las condiciones siguientes: Reconocer los créditos de la obra especificada por el autor e indicar si se realizaron cambios (puede hacerlo de cualquier forma razonable, pero no de una manera que sugiera que el autor respalda el uso que hace de su obra. No utilizar la obra para fines comerciales. En caso de remezcla, transformación o desarrollo, no puede distribuirse el material modificado.
